STAY INFORMED. VISIT NHIA.ORG/COVID19 FOR INFORMATION AND RESOURCES ABOUT CORONAVIRUS DISEASE (COVID-19).
Sterile water for injection (SWFI) and sodium chloride 0.9% for injection (NS) for use in compounding sterile preparations in the United States are in limited supply.
This shortage can directly impact patient care, thus the association is working with manufacturers and suppliers to get more information about when these issues might be resolved and looking into possible regulatory avenues for addressing these shortages.
In the meantime, NHIA has developed product shortage recommendations to help clinicians manage patients during this time when diluents, and small and large volume parenteral solutions may not be readily available, including a table of reconstitution alternatives for infusion medications.
NHIA submitted comments pointing out the advantages of home-based administration of subcutaneous Ig (SCIG) for chronic inflammatory demyelinating polyneuropathy (CIPD).
NHIA submitted comments on a CMS proposed rule (CMS-1770-P) that would affect Medicare payments and coverage of COVID-19 vaccines and monoclonal antibodies (mAbs) and coding and billing requirements related to the use of single dose containers and drug waste.
As part of a strategic focus on promoting health equity, The National Home Infusion Foundation (NHIF) recently adopted standardized categories for race and ethnicity data collection and is encouraging all providers to include voluntary questions to capture this data. NHIF will utilize this data throughout its projects to evaluate equitable access to infusion treatments in alternate sites.
© 2022, National Home Infusion Association
All Rights Reserved by NHIA
